Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Ending Cash Position : ¥951.8 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co Ending Cash Position?

Zhejiang Ausun Pharmaceutical Co's Ending Cash Position for the quarter that ended in Sep. 2023 was ¥951.8 Mil.

Zhejiang Ausun Pharmaceutical Co's quarterly Ending Cash Position increased from Mar. 2023 (¥1,065.6 Mil) to Jun. 2023 (¥1,076.8 Mil) but then declined from Jun. 2023 (¥1,076.8 Mil) to Sep. 2023 (¥951.8 Mil).

Zhejiang Ausun Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2020 (¥720.9 Mil) to Dec. 2021 (¥488.9 Mil) but then increased from Dec. 2021 (¥488.9 Mil) to Dec. 2022 (¥563.7 Mil).

Zhejiang Ausun Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co Ending Cash Position Chart

Zhejiang Ausun Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

266.97

317.63

720.93

488.93

563.75

Zhejiang Ausun Pharmaceutical Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Ending Cash Position	Get a 7-Day Free Trial															543.03	563.75	1,065.63	1,076.75	951.80

Zhejiang Ausun Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zhejiang Ausun Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	488.929	+	74.818
	=	563.7

Zhejiang Ausun Pharmaceutical Co's Ending Cash Position for the quarter that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1076.752	+	-124.953
	=	951.8

Zhejiang Ausun Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016

Website

http://www.ausunpharm.com

Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Headlines

No Headlines